EDWARDS LIFESCIENCES REPORTS SECOND QUARTER RESULTS
/PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2023. Highlights and Outlook Q2 sales grew 11...
United States Edwards Lifesciences Prnewswire Edwards Bernard Zovighian Drug Administration Product Group
Source: prnewswire.com